Mineralys Therapeutics (MLYS) Property, Plant & Equipment (Net) (2024 - 2026)

Mineralys Therapeutics (MLYS) Property, Plant & Equipment (Net) (2024 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 642,333.36
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - 5.32 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 1.64 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 1.61 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 5.27 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 1.96 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn - 31.48 Mn
10 Mineralys Therapeutics 2.28 Bn 1.63 Bn - 32,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 32,000.00
Mar 31, 2026 32,000.00
Dec 31, 2025 38,000.00
Dec 31, 2025 38,000.00
Sep 30, 2025 7,000.00
Sep 30, 2025 7,000.00
Jun 30, 2025 22,000.00
Jun 30, 2025 22,000.00
Mar 31, 2025 38,000.00
Mar 31, 2025 38,000.00
Dec 31, 2024 53,000.00
Dec 31, 2024 53,000.00
Sep 30, 2024 69,000.00
Sep 30, 2024 69,000.00
Jun 30, 2024 42,000.00
Jun 30, 2024 42,000.00
Mar 31, 2024 51,000.00
Mar 31, 2024 51,000.00